Lifecore Biomedical Inc. (LFCR)
NASDAQ: LFCR
· Real-Time Price · USD
6.87
0.10 (1.48%)
At close: Jun 02, 2025, 3:59 PM
6.87
-0.01%
After-hours: Jun 02, 2025, 04:04 PM EDT
Lifecore Biomedical Revenue Breakdown
| Period Ending | May 26, 2024 | May 28, 2023 |
|---|---|---|
| Product and Service, Other Revenue | n/a | n/a |
| Product and Service, Other Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Feb 23, 2025 | Nov 24, 2024 | Aug 25, 2024 | May 26, 2024 | Feb 25, 2024 | Nov 26, 2023 | Aug 27, 2023 | May 28, 2023 | Feb 26, 2023 | Nov 27, 2022 | Aug 28, 2022 | May 29, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.09M | 11.12M | 14.3M | 12.22M | 9.85M | 9.19M | 9.21M | 11.69M | 10.28M | 10.77M | 10.66M | 15.42M | 9.72M | 13.84M | 15.94M | 16.14M | 15.22M | 16.11M | 17.9M | 18.19M | 18.78M | 18.73M | 16.89M | 20.27M | 15.84M | 13.86M | 13.95M | 13.14M | 13.81M | 12.93M | 14.04M | 13.66M | 15.01M | 13.72M | 13.74M | 13.88M | 10.66M | 12.81M | 12.16M | 10.85M | 10.3M |
| Selling, General, and Administrative Revenue Growth | -9.23% | -22.26% | +17.00% | +24.13% | +7.22% | -0.23% | -21.22% | +13.69% | -4.59% | +1.05% | -30.88% | +58.59% | -29.71% | -13.20% | -1.22% | +6.02% | -5.50% | -10.04% | -1.56% | -3.17% | +0.29% | +10.85% | -16.65% | +27.95% | +14.32% | -0.66% | +6.18% | -4.84% | +6.75% | -7.91% | +2.83% | -8.99% | +9.36% | -0.09% | -1.01% | +30.18% | -16.82% | +5.34% | +12.10% | +5.38% | n/a |
| Research and Development Revenue | 2.04M | 1.92M | 2.19M | 2.16M | 2.17M | 2.1M | 2.15M | 2.12M | 2.23M | 2.12M | 2.05M | 2.06M | 2.06M | 2.72M | 2.83M | 2.58M | 2.56M | 2.57M | 2.51M | 2.71M | 2.75M | 2.82M | 2.82M | 3.46M | 2.74M | 2.53M | 2.83M | 3.6M | 3.11M | 3.37M | 2.72M | 3.56M | 2.01M | 1.97M | 1.94M | 1.81M | 1.9M | 1.64M | 1.88M | 1.61M | 1.75M |
| Research and Development Revenue Growth | +6.29% | -11.99% | +1.16% | -0.41% | +3.43% | -2.24% | +1.42% | -5.28% | +5.48% | +3.42% | -0.39% | 0.00% | -24.36% | -3.82% | +9.58% | +0.66% | -0.39% | +2.55% | -7.45% | -1.35% | -2.66% | +0.04% | -18.49% | +26.27% | +8.21% | -10.59% | -21.22% | +15.52% | -7.68% | +24.02% | -23.54% | +76.56% | +2.49% | +1.39% | +6.78% | -4.22% | +15.34% | -12.37% | +16.24% | -8.09% | n/a |